Filing Details
- Accession Number:
- 0001209191-22-057432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-17 06:00:15
- Reporting Period:
- 2022-11-16
- Accepted Time:
- 2022-11-17 06:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1478320 | Adaptive Biotechnologies Corp | ADPT | Biological Products, (No Disgnostic Substances) (2836) | 270907024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780662 | Kyle Piskel | C/O Adaptive Biotechnologies Corp. 1165 Eastlake Ave E Seattle WA 98109 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-16 | 959 | $8.87 | 46,706 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Billionaire Hedge Funds
